New cancer drug EVT801 tested in 32 patients – early safety results
Disease control
Completed
This early-stage study tested a new oral drug called EVT801 in 32 adults with advanced solid tumours that no longer responded to standard treatments. The main goal was to check the drug's safety and find the best dose for future studies. The trial is now complete, and results wil…
Phase: PHASE1 • Sponsor: Kazia Therapeutics Limited • Aim: Disease control
Last updated May 22, 2026 13:53 UTC